Does virus prospecting in wildlife accelerate medical countermeasures like vaccines? @avaatresh and I examine the evidence and conclude: not appreciably. Via @medrxivpreprint https://t.co/yPPYCTnGG2
What challenges does synbio face in bringing effective solutions to clinic? How are tools like AI and computational design impacting the field? Find out at #SynBioBeta2023: https://t.co/GoLuqAY8y6 @avaatresh @davehava @CurlyJungleJake@synlogic_tx@centivax
Join us for our next Science and Democracy Lecture!
AI for Cities or Cities of AI: Who should decide?
with Bill de Blasio (former mayor of NYC)
March 28, 2023
5-7pm
In-person and virtual
https://t.co/zFmewuRFuE
🎉📖Announcing Future Humans
An anthology of multi-media speculative fiction curated for the 20th Anniversary of @HarvardSTS
Read the whole anthology here https://t.co/Z3rSKKLgQf
🍾 Announcing the Symposium on Science, Technology & the Human Future, 3 days of exploration on possible futures for knowledge, life, policy, cities, and STS.
Nov 3-5, 2022
Harvard University
Celebrating 20 years of the STS Program @Kennedy_School
https://t.co/ae12J1Jbw9
Future Humans is an opportunity to collectively meditate upon the shifting ways in which we know ourselves, each other, the world, and what we hold dear — envisioning possible futures to reflect on challenges of today. Send in your submission (of any medium) today! ⬇️
Vaccine Hesitancy: Between Miracle and Mistrust
Sept 8-9, 2022
Join us and @harvard_data for two days of discussion and hands-on demonstrations of the ways researchers at Harvard and beyond are exploring questions of trust in science. https://t.co/5xCK4snJ5X @Kennedy_School
One month (sept 5) to submit to our Future Humans anthology! Imagine futures where something fundamental about the world is altered and how that changes ourselves, each other, and what we value.
https://t.co/0FTRgMDExt
Across the street from the richest college in the world, people are dying on the street. There are a lot of good people in this town, though, trying their hardest to make a difference and to help others.
https://t.co/PmN0DbkVcb
Preprint: impact of immune history and variant on SARS-CoV-2 viral kinetics and viral rebounds: https://t.co/3TVjpfi0Wx
Ct trajectories from ~3000 infections (pre-BA.2) stratified by exposure (vaccine/infection) history, symptoms, variant, and antibody titers to WA1 spike.
1/24
Interested in envisioning potential futures for humanity and inspire us to reflect upon and tackle challenges of today? We are putting together an anthology as part of our 20th anniversary and all @harvard affiliates are welcome to submit. Deadline 5 sept
https://t.co/hUW4l9PFWY
My most recent for @HarvardPolitics written early Dec, with much more to reflect on from the months since. Have we learned lessons from this pandemic? Which ones, why those/not others, for/by whom? How do we know that we've learned? How will that change policy moving forward? ⬇️
I wonder what would happen if we think of “science” as a form of service. Maybe then, it will be clearer that it is crucial to reflect upon who is served, and who is not, with the policy decisions made in the name of science.
https://t.co/GgwhOJ3sS8
Come join us for the next Science and Democracy Lecture
with
Marcia K. McNutt (President, National Academy of Sciences)
on
"For the People"
The Role of Science
March 23rd
Virtual
Register here https://t.co/jtMK2hF0IH
Congratulations to my #1 hype-woman and most wonderful human of an amazing friend and coworker @sawisner — so proud of you and can't wait for your book! #forbes30under30 https://t.co/kIevZ6Q6S0
💉 7.8 billion COVID vaccine doses have been administered
👥 53% of world population with at least 1 dose
🌍 Total doses per 100 people
High-income countries: 147
Upper-middle income: 146
Lower-middle income: 68
Low income: 7
Our data on vaccinations: https://t.co/3imP7PqURn
I think I speak for @CCDD_HSPH in saying how much we wish @michaelmina_lab well in this new exciting role and how much we will miss him as a colleague and continue to value him as a friend. https://t.co/iPAC7fqH1i
New paper on at-home self collection of blood specimens for antibody based prevalence studies for SARS-CoV-2.
A wealth of information on attitudes and willingness for participation in serological studies.
Congrats @avaatresh on getting this published, Your 1st published paper!